Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Karolinska Institute, Sweden

Name: Karolinska Institute, Sweden
Uploaded: 2008-12-04T00:00:00+00:00
Description: New drug substantially extends survival in pancreatic cancer.

ESMO 33

12 - 16 Sep 2008

Published: 4 Dec 2008

Rating:

Save

Prof. Matthias Löhr

New drug substantially extends survival in pancreatic cancer.

Categories:
Hepatobiliary pancreatic

Related Videos

Cabozantinib demonstrates significant improvement in PFS by BICR in advanced neuroendocrine tumours

Dr Jennifer Chan - Dana-Farber Cancer Institute, Boston, USA

16 Oct 2024

Selecting patients wisely for neoadjuvant therapy in HPB cancers

Dr Shailesh V. Shrikhande - Tata Memorial Hospital, Mumbai, India

21 Sep 2024

Assessment of suicide risk in cancer patients

Prof Sujit Sarkhel - SSKM Hospital, Kolkata, India

10 Sep 2024

Cancer journeys: Research from India

Ms. Soumita Ghose - Tata Medical Center, Kolkata

7 Sep 2024

Depression in cancer

Ms. Bidisha Samanta - Rocket Health, Kolkata, India

7 Sep 2024

Managing 'fear of recurrence' of cancer patients

Ms Bincy Mathew - Manipal Hospitals, Bangalore, India

7 Sep 2024

Psychological issues in familial cancer

Dr Arnab Mukherjee - Tata Medical Center, Kolkata, India

7 Sep 2024

Pancreatic, hepatic and biliary malignancies

Dr Mike Cusnir - Mount Sinai Medical Center, Miami, USA

12 Jul 2024

Administering systemic chemotherapy improves survival for patients with resectable CRCLM

Dr Giacomo Bregni - Francis Crick Institute, London, England

9 Jul 2024

Karolinska Institute, Sweden

ESMO 33

Related Videos

More from ecancer